Explore
← New search
Filters:
CN
✕
gene expression and survival cohort analysis
✕
crcos (5-fu sensitive vs resistant; pre- vs post-5-fu treatment)
✕
clear all
1 matching publication(s)
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
PMID 35425715 · Front Oncol · 2022
L1
53/100